Dashboard
Manage Tickers

XYL Xylem Inc.

NYSE xylem.com


$ 145.95 $ 1.08 (0.75 %)    

Friday, 17-Oct-2025 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 145.91
$ 144.73
$ 143.21 x 25
$ 147.19 x 28
$ 144.25 - $ 146.19
$ 99.88 - $ 151.16
1,145,085
na
35.52B
$ 1.07
$ 37.86
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2025 06-30-2025 10-Q
2 04-29-2025 03-31-2025 10-Q
3 03-03-2025 01-01-1970 10-K
4 10-31-2024 09-30-2024 10-Q
5 07-30-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-28-2024 12-31-2023 10-K
8 10-31-2023 09-30-2023 10-Q
9 08-04-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-24-2023 12-31-2022 10-K
12 11-01-2022 09-30-2022 10-Q
13 08-02-2022 06-30-2022 10-Q
14 05-04-2022 03-31-2022 10-Q
15 02-25-2022 12-31-2021 10-K
16 11-02-2021 09-30-2021 10-Q
17 08-03-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 02-26-2021 12-31-2020 10-K
20 10-29-2020 09-30-2020 10-Q
21 07-30-2020 06-30-2020 10-Q
22 05-05-2020 03-31-2020 10-Q
23 02-28-2020 12-31-2019 10-K
24 10-31-2019 09-30-2019 10-Q
25 08-01-2019 06-30-2019 10-Q
26 05-02-2019 03-31-2019 10-Q
27 02-22-2019 12-31-2018 10-K
28 10-30-2018 09-30-2018 10-Q
29 07-31-2018 06-30-2018 10-Q
30 05-01-2018 03-31-2018 10-Q
31 02-23-2018 12-31-2017 10-K
32 10-31-2017 09-30-2017 10-Q
33 08-01-2017 06-30-2017 10-Q
34 05-02-2017 03-31-2017 10-Q
35 02-23-2017 12-31-2016 10-K
36 11-01-2016 09-30-2016 10-Q
37 08-02-2016 06-30-2016 10-Q
38 05-03-2016 03-31-2016 10-Q
39 02-26-2016 12-31-2015 10-K
40 10-29-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

what-8-analyst-ratings-have-to-say-about-xylem
What 8 Analyst Ratings Have To Say About X...
10/09/2025 22:01:24

citigroup-maintains-buy-on-xylem-raises-price-target-to-173
Citigroup Maintains Buy on Xylem, Raises P...
10/09/2025 17:30:14

Citigroup analyst Andrew Kaplowitz maintains Xylem (NYSE:XYL) with a Buy and raises the price target from $168 to $173.

deal-dispatch-from-stellantis-to-snyk-major-companies-consider-exits
Deal Dispatch: From Stellantis To Snyk, Ma...
10/03/2025 20:04:54

Berkshire agreed to buy OxyChem for $9.7 billion while EA goes private for $55 billion. Also, Middleby seeks a $800 million deal.

aurelius-to-acquire-international-division-of-xylems-water-metering-business-for-undisclosed-terms-deal-expected-to-close-in-q1-2026
AURELIUS To Acquire International Division...
10/02/2025 10:57:06

Xylem Inc. (NYSE:XYL), a leading global water solutions company, has entered into a definitive agreement for AURELIUS to acquir...

how-do-investors-really-feel-about-xylem
How Do Investors Really Feel About Xylem?
09/24/2025 15:00:58

barclays-initiates-coverage-on-xylem-with-overweight-rating-announces-price-target-of-165
Barclays Initiates Coverage On Xylem with ...
09/19/2025 12:12:47

Barclays analyst William Grippin initiates coverage on Xylem (NYSE:XYL) with a Overweight rating and announces Price Target ...

breaking-down-xylem-6-analysts-share-their-views
Breaking Down Xylem: 6 Analysts Share Thei...
09/12/2025 19:00:45

mizuho-maintains-neutral-on-xylem-raises-price-target-to-140
Mizuho Maintains Neutral on Xylem, Raises ...
09/12/2025 13:54:50

Mizuho analyst Brett Linzey maintains Xylem (NYSE:XYL) with a Neutral and raises the price target from $125 to $140.

medtronic-to-rally-around-25-here-are-10-top-analyst-forecasts-for-tuesday
Medtronic To Rally Around 25%? Here Are 10...
08/26/2025 13:40:26

forecasting-the-future-6-analyst-projections-for-xylem
Forecasting The Future: 6 Analyst Projecti...
08/26/2025 12:01:18

td-cowen-maintains-hold-on-xylem-raises-price-target-to-130
TD Cowen Maintains Hold on Xylem, Raises P...
08/26/2025 10:38:34

TD Cowen analyst Joseph Giordano maintains Xylem (NYSE:XYL) with a Hold and raises the price target from $125 to $130.

pentairs-hydra-stop-purchase-to-support-sustainable-water-flow-in-growing-cities
Pentair's Hydra-Stop Purchase To Support S...
08/18/2025 13:07:15

Pentair (PNR) to acquire Hydra-Stop LLC, a U.S.-based maker of specialty valve solutions, for $290M. Deal expected to close by ...

ubs-maintains-buy-on-xylem-raises-price-target-to-168
UBS Maintains Buy on Xylem, Raises Price T...
08/05/2025 13:37:54

UBS analyst Damian Karas maintains Xylem (NYSE:XYL) with a Buy and raises the price target from $164 to $168.

stifel-maintains-buy-on-xylem-raises-price-target-to-175
Stifel Maintains Buy on Xylem, Raises Pric...
08/01/2025 16:22:49

Stifel analyst Nathan Jones maintains Xylem (NYSE:XYL) with a Buy and raises the price target from $162 to $175.

meta-microsoft-power-wall-street-to-new-records-despite-inflation-jump-whats-moving-markets-thursday
Meta, Microsoft Power Wall Street To New R...
07/31/2025 17:21:14

A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp.

xylem-raises-fy2025-adj-eps-guidance-from-450-470-to-470-485-vs-463-est-raises-fy2025-sales-guidance-from-8700b-8800b-to-8900b-9000b-vs-8753b-est
Xylem Raises FY2025 Adj EPS Guidance from ...
07/31/2025 10:58:42

Xylem (NYSE:XYL) raises FY2025 Adj EPS guidance from $4.50-$4.70 to $4.70-$4.85 vs $4.63 analyst estimate. Raises FY2025 sales ...

xylem-q2-adj-eps-126-beats-115-estimate-sales-2301b-beat-2206b-estimate
Xylem Q2 Adj. EPS $1.26 Beats $1.15 Estima...
07/31/2025 10:56:35

Xylem (NYSE:XYL) reported quarterly earnings of $1.26 per share which beat the analyst consensus estimate of $1.15 by 9.95 perc...

Core News & Articles
Earnings Scheduled For July 31, 2025
07/31/2025 08:32:50

6-analysts-assess-xylem-what-you-need-to-know
6 Analysts Assess Xylem: What You Need To ...
07/21/2025 22:01:10

stifel-maintains-buy-on-xylem-raises-price-target-to-162
Stifel Maintains Buy on Xylem, Raises Pric...
07/21/2025 12:57:22

Stifel analyst Nathan Jones maintains Xylem (NYSE:XYL) with a Buy and raises the price target from $141 to $162.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION